EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Metabolic‐Immune Crosstalk in Colorectal Cancer: Mechanisms and Therapeutic Opportunities

Yan Lu iD, Xingyi Li, Xijia Yuan, Xiaowen Guo, Dake Chu iD

Immunology · 11.11.2026

DOI: 10.1111/imm.70230 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunology, online erschienen am 11.11.2026. Verfasst von Yan Lu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. Die Arbeit nennt 114 Literaturangaben. Gefördert von: the National Natural Science Foundation of China, the Shaanxi Outstanding Youth Science Foundation Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) remains a major cause of cancer‐related morbidity and mortality worldwide, with its progression and therapeutic resistance increasingly recognized as consequences of complex metabolic and immune interactions within the tumour microenvironment (TME). Recent advances in single‐cell and spatial multi‐omics technologies have enabled detailed characterisation of metabolic heterogeneity among TME components, uncovering how distinct metabolic states influence immune function and therapeutic responses. In this review, we summarize recent advances in our understanding of metabolic regulation in the CRC microenvironment, with a particular focus on how distinct immune cell populations contribute to tumour progression and immune suppression through diverse metabolic pathways. We discuss key metabolite‐driven signalling networks involving lactate, short‐chain fatty acids, bile acids, and amino acid derivatives, and examine how these pathways influence immune cell function and tumour‐immune interactions. Furthermore, we highlight emerging therapeutic approaches targeting the metabolic‐immune axis, including glutaminase inhibitors, CD36 antagonists, and combination regimens integrating metabolic intervention with immune checkpoint inhibitors. By integrating recent mechanistic discoveries with therapeutic perspectives, this review provides an updated overview of the metabolic‐immune landscape in CRC and discusses potential strategies to exploit metabolic vulnerabilities for improving immunotherapy efficacy and overcoming treatment resistance.

Schlagwörter

Stichwörter der Autor:innen

colorectal cancerimmunometabolismmetabolic reprogrammingtumour microenvironment

Autor:innen und Institutionen

  • Department of Gastroenterology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.

ORCID-Profile: Yan Lu, Dake Chu

Förderung

  • the National Natural Science Foundation of China
  • the Shaanxi Outstanding Youth Science Foundation Project

Zitieren

APA

Lu, Y., Li, X., Yuan, X., Guo, X., & Chu, D. (2026). Metabolic‐Immune Crosstalk in Colorectal Cancer: Mechanisms and Therapeutic Opportunities. Immunology. https://doi.org/10.1111/imm.70230

Vancouver

Lu Y, Li X, Yuan X, Guo X, Chu D. Metabolic‐Immune Crosstalk in Colorectal Cancer: Mechanisms and Therapeutic Opportunities. Immunology. 2026. doi:10.1111/imm.70230

BibTeX
@article{Lu2026,
  author = {Lu, Yan and Li, Xingyi and Yuan, Xijia and Guo, Xiaowen and Chu, Dake},
  title = {Metabolic‐Immune Crosstalk in Colorectal Cancer: Mechanisms and Therapeutic Opportunities},
  journal = {Immunology},
  year = {2026},
  doi = {10.1111/imm.70230}
}
Kostenlos starten →